Healthy Skepticism Library item: 10289

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Nguyen VK, Grennan T, Peschard K, Tan D, Tiendrebeogo I.
Antiretroviral use in Ouagadougou, Burkina Faso.
AIDS 2003 Jul; 17:
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0269-9370&volume=17&issue=&spage=S109

Abstract:

Burkina Faso has the second highest seroprevalence rate for HIV in West Africa, estimated at 6.5% of the population. Although it is one of the poorest countries in the world, antiretrovirals have been used on an extremely limited basis in Burkina Faso since at least the early 1990s. In this article we will review the evolution of antiretroviral availability in this country, describe the mechanisms by which drugs are being accessed, and review our experience with expanding antiretroviral access through drug donations in community-based settings. Finally, we will discuss some of the implications for future attempts to expand access to treatment for people living with HIV in Africa.

Keywords:
Anti-HIV Agents/economics Anti-HIV Agents/supply & distribution* Anti-HIV Agents/therapeutic use Burkina Faso Community Networks Developing Countries* Drug Costs HIV Infections/drug therapy* Humans